ELRIG announces keynote speakers for Drug Discovery 2025

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

9 May 2025

Industry news

ELRIG, has announced the keynote speakers for its flagship event, Drug Discovery 2025. Taking place at the ACC in Liverpool, UK from 21–22 October, the conference will feature presentations from Professor Heather Pinkett (Northwestern University) and Dr. Dafydd Owen (Pfizer Medicine Design).

Held under the theme 'A Festival of Life Science', Drug Discovery 2025 is a celebration that aims to unite scientists from industry and academia working toward the same goal: improving human health through more effective drug discovery.

The event offers free access to over 150 talks across 14 scientific tracks, covering topics such as advances in robotics and automation, advanced models for drug discovery, hit-finding approaches in neurodegenerative disease therapeutics, chemical biology and omics, translating ideas into therapies, as well as sustainable drug development.

ELRIG is also collaborating with organizations including SLAS, the British Pharmacological Society, the Royal Society of Chemistry, Cancer Research Horizons, The Protein Society, SiLA and Alzheimer’s Research UK to bring a broad range of content.

To further its international outreach, ELRIG has partnered with VisitBritain to provide the opportunity for global drug discovery researchers to experience the UK life science sector first-hand and contribute their perspectives to the conversation.

The conference will host 200+ exhibitors, a 'Breakthrough Zone' for start-ups, a Tech Theatre, and dedicated events for early-career professionals (ECPs), including 'Network Like a Boss' and 'Meet & Greet' sessions. Awards will also recognize innovation, rising stars from the ECP community, and individuals who have made outstanding contributions to both ELRIG and the drug discovery field.

Prof Heather Pinkett, Associate Professor, Department of Molecular Biosciences at Northwestern University, said, “I’m excited to engage with scientists from across academia and industry and to deliver the opening keynote at Drug Discovery 2025.”

Dr. Dafydd Owen, Senior Scientific Director at Pfizer Medicine Design, added, “It’s an honour to share the science behind PAXLOVID and to celebrate global innovation in drug discovery at ELRIG’s flagship event.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Automation Supplies / AccessoriesAutomated accessories and consumables make lab processes fast, efficient and reliable. Useful automation accessories include microplate sealers, label printers and reagent reservoirs.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.Discovery SoftwareComputational techniques used in both the chemistry and biology aspects of drug discovery, for data acquisition, processing and storage. Software is used for analysis of pathways, target identification, genomics, proteomics, modelling, lead identification, compound analysis and drug modelling among many others. ELRIGNeurodegenerationNeurodegeneration refers to the progressive deterioration of the structure and function of the nervous system, often seen in diseases like Alzheimer's and Parkinson's. Research focuses on early detection and potential therapies. Explore neurodegeneration research tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Cancer ResearchCancer research aims to understand the mechanisms of cancer development and progression to improve prevention, diagnosis, and treatment. From molecular biology to clinical trials, research spans a wide range of disciplines, including immunotherapy, targeted therapies, and drug discovery. Explore the best cancer research products in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.